<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>4369313 Figure_1-C</id>
    <infon key="sourcedata_document">1945</infon>
    <infon key="doi">10.15252/embj.201490542</infon>
    <infon key="pmc_id">4369313</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Gene expression heatmaps of selected genes from the bound and activated and bound and repressed groups show activation of key hematopoietic target genes and repression of key cardiac target genes in Scl&#8208;expressing mesoderm as compared to Scl&#8208;deficient mesoderm. Control [Scl+/hCD4, divided into Scl&#8208;expressing (Scl+) and non&#8208;expressing cells (Scl&#8722;)] and SclKOEBs are shown.</text>
    </passage>
  </document>
  <document>
    <id>4369313 Figure_1-D</id>
    <infon key="sourcedata_document">1945</infon>
    <infon key="doi">10.15252/embj.201490542</infon>
    <infon key="pmc_id">4369313</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Scl and control IgGChIP&#8208;seq tracks show examples of Scl binding sites near hematopoietic (Runx1 and Gata2) and cardiac (Gata4 and Gata6) genes in Flk1+mesoderm (MES).</text>
    </passage>
  </document>
  <document>
    <id>4369313 Figure_1-E</id>
    <infon key="sourcedata_document">1945</infon>
    <infon key="doi">10.15252/embj.201490542</infon>
    <infon key="pmc_id">4369313</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Verification of Scl binding sites marked with asterisks in (D) using ChIP&#8208;PCR, average enrichment of at least three independent biological experiments over negative control region (chr16: 92230219-92230338) with SEM are shown.</text>
    </passage>
  </document>
  <document>
    <id>4369313 Figure_1-F</id>
    <infon key="sourcedata_document">1945</infon>
    <infon key="doi">10.15252/embj.201490542</infon>
    <infon key="pmc_id">4369313</infon>
    <infon key="figure">Figure 1-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F</infon>
    <passage>
      <offset>0</offset>
      <text>F Verification of Scl&#8208;dependent gene expression using qRT-PCR. Average of three biological replicates with SD are shown.</text>
    </passage>
  </document>
  <document>
    <id>4369313 Figure_1-H</id>
    <infon key="sourcedata_document">1945</infon>
    <infon key="doi">10.15252/embj.201490542</infon>
    <infon key="pmc_id">4369313</infon>
    <infon key="figure">Figure 1-H</infon>
    <infon key="sourcedata_figure_dir">Figure_1-H</infon>
    <passage>
      <offset>0</offset>
      <text>H Heatmaps show Scl binding to majority of activated hematopoietic and repressed cardiac transcription factors and other proteins. See also Supplementary Fig S1 and Supplementary Table S1A-E.</text>
    </passage>
  </document>
  <document>
    <id>4369313 Figure_2-A</id>
    <infon key="sourcedata_document">1945</infon>
    <infon key="doi">10.15252/embj.201490542</infon>
    <infon key="pmc_id">4369313</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Distribution of Scl binding sites relative to TSS in Scl&#8208;bound activated or repressed genes shows that majority of Scl binding sites locate away from TSS. Chi&#8208;square test was used to assess differences in the distribution.</text>
    </passage>
  </document>
  <document>
    <id>4369313 Figure_2-B</id>
    <infon key="sourcedata_document">1945</infon>
    <infon key="doi">10.15252/embj.201490542</infon>
    <infon key="pmc_id">4369313</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Percent of tissue&#8208;specific enhancers validated by LacZ reporter mice (Vista enhancer browser) that overlap with SclMES binding sites shows that Scl binds to experimentally verified heart enhancers more often compared to enhancers from other tissues.</text>
    </passage>
  </document>
  <document>
    <id>4369313 Figure_2-C</id>
    <infon key="sourcedata_document">1945</infon>
    <infon key="doi">10.15252/embj.201490542</infon>
    <infon key="pmc_id">4369313</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Percent of SclMES binding sites that overlap with heart enhancers in E11.5 embryos defined by p300 binding (Blow et al, ) is higher than overlap with enhancers from other tissues.</text>
    </passage>
  </document>
  <document>
    <id>4369313 Figure_2-D</id>
    <infon key="sourcedata_document">1945</infon>
    <infon key="doi">10.15252/embj.201490542</infon>
    <infon key="pmc_id">4369313</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>D SclMES binding sites overlap with experimentally verified heart&#8208;specific enhancers upstream of Myocardin and Nkx2.5 genes and with hematopoietic enhancers within Runx1 and Gata2 genes.</text>
    </passage>
  </document>
  <document>
    <id>4369313 Figure_2-E</id>
    <infon key="sourcedata_document">1945</infon>
    <infon key="doi">10.15252/embj.201490542</infon>
    <infon key="pmc_id">4369313</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Percent of enhancers from different cardiac developmental stages identified by H3K4me1 (enhancers) and H3K4me1 combined with H3k27ac (active enhancers) (Wamstad et al, ) that overlap with SclMES binding sites.</text>
    </passage>
  </document>
  <document>
    <id>4369313 Figure_2-F</id>
    <infon key="sourcedata_document">1945</infon>
    <infon key="doi">10.15252/embj.201490542</infon>
    <infon key="pmc_id">4369313</infon>
    <infon key="figure">Figure 2-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F</infon>
    <passage>
      <offset>0</offset>
      <text>F Average H3K4me1 (left) and H3K27ac (right) profiles around all 4,393 Scl binding sites show tissue&#8208;specific enrichment in Flk1+mesoderm (MES), cardiac precursors (CP) and cardiomyocytes (CM) but not in ESC (mouseES cells) mouse embryonic fibroblasts (MEF) and embryonic limbs (LIMB).</text>
    </passage>
  </document>
  <document>
    <id>4369313 Figure_2-G</id>
    <infon key="sourcedata_document">1945</infon>
    <infon key="doi">10.15252/embj.201490542</infon>
    <infon key="pmc_id">4369313</infon>
    <infon key="figure">Figure 2-G</infon>
    <infon key="sourcedata_figure_dir">Figure_2-G</infon>
    <passage>
      <offset>0</offset>
      <text>G Correlation analysis of H3K4me1 (left) and H3K27ac (right) levels between WT and SclKOMES and ES cells and MES (Wamstad et al, ) around 4,393 Scl binding sites shows that establishment of these marks occurs independently of Scl.</text>
    </passage>
  </document>
  <document>
    <id>4369313 Figure_2-H</id>
    <infon key="sourcedata_document">1945</infon>
    <infon key="doi">10.15252/embj.201490542</infon>
    <infon key="pmc_id">4369313</infon>
    <infon key="figure">Figure 2-H</infon>
    <infon key="sourcedata_figure_dir">Figure_2-H</infon>
    <passage>
      <offset>0</offset>
      <text>H Scl, H3K4me1 and H3K27ac ChIP&#8208;seq tracks show comparable levels of H3K4me1 and H3K27ac in WT and SclKO mesoderm around cardiac (Gata6, Tbx5) and hematopoietic (Eto2, Gfi1b) genes.</text>
    </passage>
  </document>
  <document>
    <id>4369313 Figure_3-C</id>
    <infon key="sourcedata_document">1945</infon>
    <infon key="doi">10.15252/embj.201490542</infon>
    <infon key="pmc_id">4369313</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>C ChIP&#8208;seq tracks with Scl binding in Flk1+MES, HPC7, FL erythroblasts and MEL (mouse erythroleukemia cells) around cardiac (Gata4, Myocd, Nkx2.5) and hematopoietic (Gata1, Gata2 and Lyl1) genes show that binding to cardiac genes occurs only in mesoderm, while binding to hematopoietic genes is maintained throughout hematopoietic development.</text>
    </passage>
  </document>
  <document>
    <id>4369313 Figure_3-D</id>
    <infon key="sourcedata_document">1945</infon>
    <infon key="doi">10.15252/embj.201490542</infon>
    <infon key="pmc_id">4369313</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Comparison of the location of developmental stage&#8208;specific Scl binding sites relative to TSS shows that Scl binding near TSS occurs more often in later hematopoietic development compared to mesoderm.</text>
    </passage>
  </document>
  <document>
    <id>4369313 Figure_3-E</id>
    <infon key="sourcedata_document">1945</infon>
    <infon key="doi">10.15252/embj.201490542</infon>
    <infon key="pmc_id">4369313</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Heatmaps of combinatorial clustering of H3K4me1 around Sclmesodermal binding sites in MES, HPC7 and MEL reveal two major clusters: Cluster L loses H3K4me1, H3K27ac and Scl binding during hematopoietic differentiation and is enriched for genes involved in heart development; cluster R retains H3K4me1, H3K27ac and Scl binding during hematopoietic differentiation and is enriched for hematopoiesis&#8208;related genes. Selected GO terms among top 10 most enriched are shown.</text>
    </passage>
  </document>
  <document>
    <id>4369313 Figure_4-A</id>
    <infon key="sourcedata_document">1945</infon>
    <infon key="doi">10.15252/embj.201490542</infon>
    <infon key="pmc_id">4369313</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Heatmaps of H3K4me1, H3K27ac, H3K27me3 and H3K9me3 histone modifications in FL erythroblasts around SclMES binding sites in cluster L and cluster R show no gain of common repressive histone marks in cluster L.</text>
    </passage>
  </document>
  <document>
    <id>4369313 Figure_4-B</id>
    <infon key="sourcedata_document">1945</infon>
    <infon key="doi">10.15252/embj.201490542</infon>
    <infon key="pmc_id">4369313</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>B H3K27me3 ChIP&#8208;seq tracks in ES cells (ESC), Flk1+mesoderm (MES) and FL erythroblasts (Ery) show that cardiac genes Gata6, Tbx5 and Gata4 harbor H3K27me3 at the TSS (pink) but not at Scl binding sites (gray).</text>
    </passage>
  </document>
  <document>
    <id>4369313 Figure_4-C</id>
    <infon key="sourcedata_document">1945</infon>
    <infon key="doi">10.15252/embj.201490542</infon>
    <infon key="pmc_id">4369313</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Average H3K27me3 (left) and H3K27ac (right) levels in FL erythroblasts around the TSS of extended list of Scl activated and repressed genes show that Scl repressed genes have on average more H3K27me3 and less H3K27ac as compared to Scl activated genes.</text>
    </passage>
  </document>
  <document>
    <id>4369313 Figure_4-D</id>
    <infon key="sourcedata_document">1945</infon>
    <infon key="doi">10.15252/embj.201490542</infon>
    <infon key="pmc_id">4369313</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Ezh2ChIP&#8208;seq tracks in WT and SclKO mesoderm showing that Ezh2 recruitment to the TSS of cardiac genes Gata6, Tbx5 and Gata4 is not Scl dependent.</text>
    </passage>
  </document>
  <document>
    <id>4369313 Figure_4-E</id>
    <infon key="sourcedata_document">1945</infon>
    <infon key="doi">10.15252/embj.201490542</infon>
    <infon key="pmc_id">4369313</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Average Ezh2 enrichment in WT (left) and SclKOmesoderm (right) for inactive enhancers (defined by having H3K4me1 and H3K27me3 modifications (Wamstad et al, ) and distance greater than 5 kb from TSS) and for Scl binding sites shows no Ezh2 enrichment at Scl binding sites.</text>
    </passage>
  </document>
  <document>
    <id>4369313 Figure_4-F</id>
    <infon key="sourcedata_document">1945</infon>
    <infon key="doi">10.15252/embj.201490542</infon>
    <infon key="pmc_id">4369313</infon>
    <infon key="figure">Figure 4-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F</infon>
    <passage>
      <offset>0</offset>
      <text>F Average Ezh2 enrichment at the TSS of extended list of Scl activated and repressed genes is similar in WT (left) and SclKOmesoderm (right).</text>
    </passage>
  </document>
  <document>
    <id>4369313 Figure_4-G</id>
    <infon key="sourcedata_document">1945</infon>
    <infon key="doi">10.15252/embj.201490542</infon>
    <infon key="pmc_id">4369313</infon>
    <infon key="figure">Figure 4-G</infon>
    <infon key="sourcedata_figure_dir">Figure_4-G</infon>
    <passage>
      <offset>0</offset>
      <text>G Heatmaps of Lsd1 enrichment in ES cells, WT and SclKOmesoderm and in granulocytes (Gr) (Kerenyi et al, ) in cluster L and cluster R show co&#8208;localization of Lsd1 binding with Scl binding sites and reveal that recruitment of Lsd1 can happen independently of Scl.</text>
    </passage>
  </document>
  <document>
    <id>4369313 Figure_4-H</id>
    <infon key="sourcedata_document">1945</infon>
    <infon key="doi">10.15252/embj.201490542</infon>
    <infon key="pmc_id">4369313</infon>
    <infon key="figure">Figure 4-H</infon>
    <infon key="sourcedata_figure_dir">Figure_4-H</infon>
    <passage>
      <offset>0</offset>
      <text>H Lsd1ChIP&#8208;seq tracks (ES cells, WT and SclKOFlk1+mesoderm and granulocytes) and H3K4me1 ChIP&#8208;seq track (granulocytes) show that Lsd1 enrichment coincides with SclMES binding sites nearby cardiac genes Gata6 and Myocd in WT and SclKOFlk1+mesoderm.</text>
    </passage>
  </document>
  <document>
    <id>4369313 Figure_5-C</id>
    <infon key="sourcedata_document">1945</infon>
    <infon key="doi">10.15252/embj.201490542</infon>
    <infon key="pmc_id">4369313</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Gata4, Hand1 and SclChIP&#8208;seq tracks with cardiac and hematopoietic gene regions show examples of three subgroups of enhancers-those bound by Scl, Hand1 and Gata4 (gray), Scl and Gata4 (orange) and those bound only by Scl (blue).</text>
    </passage>
  </document>
  <document>
    <id>4369313 Figure_5-D-H</id>
    <infon key="sourcedata_document">1945</infon>
    <infon key="doi">10.15252/embj.201490542</infon>
    <infon key="pmc_id">4369313</infon>
    <infon key="figure">Figure 5-D-H</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D-H</infon>
    <passage>
      <offset>0</offset>
      <text>D-H Scl binding sites that overlap with both Hand1 and Gata4 (gray) or with Hand1 (green) or Gata 4 (orange) alone show higher evolutionary conservation (D) and higher average enrichment of Scl (E), H3K4me1 (F), H3K27ac (G) and Lsd1 (H) in mesoderm compared to sites bound by Scl alone (blue).</text>
    </passage>
  </document>
  <document>
    <id>4369313 Figure_5-I</id>
    <infon key="sourcedata_document">1945</infon>
    <infon key="doi">10.15252/embj.201490542</infon>
    <infon key="pmc_id">4369313</infon>
    <infon key="figure">Figure 5-I</infon>
    <infon key="sourcedata_figure_dir">Figure_5-I</infon>
    <passage>
      <offset>0</offset>
      <text>I Average expression changes between Scl&#8208;expressing and Scl&#8208;deficient mesoderm shows that genes that are regulated by enhancers bound by all three (Scl, Hand1 and Gata4) factors or two factors (Scl and Hand1 or Scl and Gata4) show higher absolute expression changes compared to those bound by Scl alone.</text>
    </passage>
  </document>
  <document>
    <id>4369313 Figure_5-J</id>
    <infon key="sourcedata_document">1945</infon>
    <infon key="doi">10.15252/embj.201490542</infon>
    <infon key="pmc_id">4369313</infon>
    <infon key="figure">Figure 5-J</infon>
    <infon key="sourcedata_figure_dir">Figure_5-J</infon>
    <passage>
      <offset>0</offset>
      <text>J Analysis of Scl&#8208;regulated key hematopoietic and cardiac genes shows that many of them can be bound also by cardiac factors, Scl, Gata4 and Hand1 (orange); Scl and Hand1 binding (green); Scl and Gata4 binding (orange); and Scl binding alone (blue).</text>
    </passage>
  </document>
  <document>
    <id>4369313 Figure_6-A</id>
    <infon key="sourcedata_document">1945</infon>
    <infon key="doi">10.15252/embj.201490542</infon>
    <infon key="pmc_id">4369313</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>A FACS analysis of day 7 EBs with markers CD41 and c&#8208;Kit shows efficient generation of HSPCs from WT, but not SclKO or Gata1,2KO cells. Average of six independent experiments with SEM is shown.</text>
    </passage>
  </document>
  <document>
    <id>4369313 Figure_6-B</id>
    <infon key="sourcedata_document">1945</infon>
    <infon key="doi">10.15252/embj.201490542</infon>
    <infon key="pmc_id">4369313</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>B FACS analysis of day 5.25 EBs with markers CD41, Flk1, Tie2 and CD31 shows the generation of hemogenic endothelial cells from WT and Gata1,2KO cells, but not SclKO cells. Average of five independent biological experiments with SEM is shown.</text>
    </passage>
  </document>
  <document>
    <id>4369313 Figure_6-C</id>
    <infon key="sourcedata_document">1945</infon>
    <infon key="doi">10.15252/embj.201490542</infon>
    <infon key="pmc_id">4369313</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Assessment of the developmental potential of day 4.75 EB CD41&#8722;CD31+Tie2+endothelial cells on OP9 for 14 days shows the generation of CD45+ hematopoietic cells from WT cells but not Gata1,2KO or SclKO cells, and troponin T+cardiomyocytes from SclKO cells, but not WT or Gata1,2KO cells. Average of four independent experiments with SEM is shown.</text>
    </passage>
  </document>
  <document>
    <id>4369313 Figure_6-D</id>
    <infon key="sourcedata_document">1945</infon>
    <infon key="doi">10.15252/embj.201490542</infon>
    <infon key="pmc_id">4369313</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Heatmaps show gene expression differences in subsets of hematopoietic genes between Gata1,2KO and WT or SclKO day 4.75 CD41&#8722;CD31+Tie2+endothelial cells. Cardiac derepression is observed only in SclKO cells. *designates non&#8208;functional transcripts.</text>
    </passage>
  </document>
  <document>
    <id>4369313 Figure_7-B</id>
    <infon key="sourcedata_document">1945</infon>
    <infon key="doi">10.15252/embj.201490542</infon>
    <infon key="pmc_id">4369313</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>B-D SclChIP&#8208;seq tracks in WT and Gata1,2KO Flk1+MES show Gata1&#8208; and 2&#8208;independent Scl binding to cardiac regulators (Myocardin, Gata4) (B).</text>
    </passage>
  </document>
  <document>
    <id>4369313 Figure_7-C-D</id>
    <infon key="sourcedata_document">1945</infon>
    <infon key="doi">10.15252/embj.201490542</infon>
    <infon key="pmc_id">4369313</infon>
    <infon key="figure">Figure 7-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>B-D SclChIP&#8208;seq tracks in WT and Gata1,2KO Flk1+MES show Gata1&#8208; and 2&#8208;independent Scl binding to Gata1&#8208; and 2&#8208;independent Scl binding to key hemato&#8208;vascular regulators (Lyl1, Fli1) (C) and Gata1&#8208; and/or 2&#8208;dependent Scl binding to key HSPC transcription factors (Myb, Runx1) (D).</text>
    </passage>
  </document>
</collection>
